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Background
Heterologous prime-boost vaccinations have emerged as
a promising strategy to generate protective immunity
against a variety of pathogens. Our previous clinical
work has demonstrated that an HIV-1 gp120 DNA
prime-protein boost vaccine, DP6-001, elicits enhanced
neutralizing antibody responses as well as cell-mediated
immune responses in humans. However, the roles of
adjuvants remain largely unknown in the context of
such combination vaccines.
Methods
In a mouse model, we studied the effects of adjuvants
QS-21, Alum, and MPL, in the context of DP6-001.
Both gp120-specific antibody and T cell responses were
monitored by ELISA and intracellular cytokine staining
(ICS), respectively. Innate cytokine profiles were deter-
mined in sera collected 6 hours post-immunization by
Cytometric Bead Array (CBA) and Luminex assays.
Results
Serum anti-Env IgG titers were comparable between
adjuvant groups. All immunized animals demonstrated
comparable positive gp120-specific CD4+ and CD8+ T
cell responses by ICS. Adjuvant profiles were largely
determined by sera cytokines following protein boosting.
QS-21 was distinguished by elevated IL-4, IFNg, MIP-
1b, and IL-1b. MPL was characterized by elevated G-
CSF, KC, and RANTES. Both adjuvant groups demon-
strated elevated IL-6. Production of these sera cytokine
profiles required DNA priming.
Conclusion
Our data indicated that different adjuvants generate
unique patterns of biomarkers, indicating that different
mechanisms are involved in their action. Our results
also provided useful guidance in the selection of an
adjuvant for inclusion in future prime-boost strategies,
with the goal of enhancing immunogenicity while mini-
mizing reactogenicity.
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